The U.S. Food and Drug Administration (FDA) today announced its approval for a breakthrough treatment that will bring the promise of immunotherapy and new hope to thousands of patients diagnosed with mantle cell lymphoma (MCL) whose previous treatments fail to bring them lasting remissions. There are more than 70 subtypes of lymphoma, and MCL is a particularly aggressive form of this blood cancer with a short remission from standard therapies. The median overall survival rate is betwe...
The Georgia Virtual Blood Cancer Conference is Saturday!
The Georgia/South Carolina Region of The Leukemia & Lymphoma Society is proud to present this free VIRTUAL education event to blood cancer patients, survivors, family members, caregivers and healthcare professionals*. Experts in the areas of blood cancer research, treatment, and survivorship will present information on each topic. Our goal is to educate conference participants about treatment options, emerging therapies, management of survivorship issues and LLS resources.
*This is NOT a continuing education (CE) program